Immuron Ltd ADR (IMRN)

Immuron Ltd ADR (IMRN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $9.4M; returns 1 day +0.4%, 1 week -2.9%, 1 year -55.9%.

Immuron Limited (IMRN) is an Australian biopharmaceutical company focused on the research, development, and commercialization of orally delivered targeted polyclonal antibodies for infectious and inflammatory diseases. The company operates through two primary segments: Research and Development, and Hyper-immune Products.

Groups IMRN belongs to

• Biopharmaceutical
• Antibody Therapeutics
• Infectious Diseases
• Digestive Health
• Over-the-Counter Drugs
• Travel
• Gastroenterology
• Healthcare
• Clinical Stage Biopharma

IMRN financial model: income statement, cash flow and balance sheet